Pharm Group is a translational medicine-focused biotechnology company that was launched in 2015 to commercialize the breakthroughs that have already been rapidly shaping the regenerative and personalized medicine industries. The company operates a state-of-the-art, cGMP level "Cell Factory” to provide these industries with a standardized cell processing platform to enhance the delivery of healthcare through cellular-based therapies and applications. The cell processing, bio-banking, manufacturing and application are in both personized and large scale batch which address rejuvenation, burn and wound healing, joint repair, immune disorders, anti-cancer treatment and management, and personalized health care. Pharm Group is a magnet for transnational capital inflows which attracted talent scientists and healthcare professionals both from home and abroad.
Pharm Group's growth strategy is centered on fully capitalizing the scientific breakthroughs. Through its scientific efforts, the company has built a strong, strategic portfolio of intellectual property, patent applications, and proprietary operating procedural processes that form its standardized cellular platform in the cutting edge of translational medicine.
Company culture
Becoming a leading bio-technological company specializes in scientific research and translational application of regenerative medicine.
International Layout
Pharm Group is headquartered in Guangzhou, China. The total investment is over one hundred million RMB. The company covers an area of 6,000 square meters in the central business district of Guangzhou. Pharm group built up "cell factories" and molecular biology laboratories in strict accordance with GMP (Good Manufacturing Practice) standards in Guangzhou and Shanghai. The cleanliness level of aseptic processing room is 10,000 class level, laminar flow biosafety cabinet is 100 class level, which boasts the best facilities in China. It has set up global branches in Hong Kong, Beijing, Shanghai and USA with total investment over one hundred million RMB.
